
TSE:OTEX
This summary was created by AI, based on 22 opinions in the last 12 months.
Open Text (OTEX) has received a mixed bag of reviews from industry experts. Several commentators highlighted concerns regarding the company's growth prospects, citing a low organic growth rate of 1-2% and significant challenges posed by the rise of AI technologies, which may disrupt traditional software pricing models. Some experts described it as deeply undervalued with a low PE ratio of 5.2x and a 4% dividend yield, arguing that it could be a buying opportunity for long-term investors. However, many stressed the importance of cautious investment, pointing to a broken long-term pattern in its chart and advising against purchasing at current levels. The overall sentiment suggests that while it's a value stock, risks remain about its management, acquisition strategy, and ability to adapt to changing market conditions.
Global, site-based and cloud-based. Installed base of 150M+ users. No customer concentration risk. 80% of revenues are recurring. Sluggish organic grower, but very capable serial acquirer. Just closed most skeptical acquisition, seems to be going well. Shareholder return over 20 years of 13.4%, 10x the TSX tech index. Deeply discounted at 9x earnings vs. its 10-year average of 13x. Yield is 2.38%.
(Analysts’ price target is $63.80)
OTEX reported a net loss of US$48.7 million in its fourth quarter, down from earnings of $102.2 million last year. This was attributed to acquisition expenses. Revenue of $1.5 billion rose 66.2% year-over-year marginally beating estimates. Annual recurring revenue of $1.2 billion rose 56.4% year-over-year, and cloud revenues of $452 million were up 9.7% year-over-year. Quarterly enterprise cloud bookings rose 12.3% to $164 million. Adjusted EBITDA came in at $463 million, reflecting a margin of 31.0%. The company also announced opentext.ai, a strategic approach to advance how customers can apply artificial intelligence with OpenText software. Management guided the MCRO acquisition to return to organic growth in FY2024, earlier than expected. We think it is still some time to see valuation recovery for OTEX. We would consider anything under $48 to be a reasonable entry point.
Unlock Premium - Try 5i Free